Porous silicon-based materials are attracting much recent interest for bio-applications including sensing, imaging and drug delivery.
1-6 Particles of porous silicon with attractive properties of high surface area,
7,8 intrinsic luminescence and bio-degradability
1a,2-4,11 have become a very promising scaffold for delivering drugs. Polymer-coated porous silicon nanoparticles (PSiNPs) have been shown to be an effective chemotherapeutic drug delivery system.
1a The method for drug transportation in these studies was based on the electrostatic interaction and/or physical adsorption of specific drugs to the particles.
1-4 A key challenge for drug delivery applications is to utilize and control the access to the pores of the PSiNPs in order to generate a stimulus-responsive system that can transport and release the payload on demand without premature release. Similar efforts on mesoporous silica nanoparticles (MSNPs) have led to the development of molecular nanovalves that control the pore openings.
9 Because the surface of the PSiNPs is usually terminated with a native silica layer, it is reasonable to expect that nanovalve-controlled systems similar to those that have been developed on silica nanoparticles can also be adapted onto the PSiNP platform. In this communication, we demonstrate the first example of a mechanized PSiNPs system with access to the pore structure controlled by nanovalves chemically bonded on the surface of the PSiNPs. We further show that these PSiNPs can be used as an in vitro delivery system to the human pancreatic carcinoma PANC-1 cells where the cargo is confined in the particles at pH 7.4 and released only on exposure to the decreased pH in endocytic vesicles.
Traditionally, porous silicon is produced by applying a voltage bias to a silicon wafer in hydrofluoric acid containing solutions.
10 In this study, the rod-like PSiNPs were prepared from breaking down porous silicon nanowires (PSiNWs), that were generated on a silicon wafer via a Ag-assisted electroless chemical etching method.
8 Currently, several mechanisms have been proposed to explain the porosification process.
8c,11,12 The mechanism we suggested her is based on our previous work
8c and schematically illustrated in . Silver nanoparticles, which were pre-deposited on the silicon wafer (), will etch pits down into the wafer. The nanowires were consequently formed as the result of the pit walls left between particles. In the process, the Ag nanoparticles at the bottom of these pits can re-dissolve in the etching solution, diffuse up and nucleate again () on the sidewalls of the as-formed silicon nanowires, serving as a new etching site and generating the pores (). By using this method, PSiNWs can be generated without external electricity, and the nanowire lengths as well as their pore sizes can be easily tuned by controlling the reaction time and conditions.
8c
displays the cross sectional SEM image of an as-prepared PSiNW array on the substrate. The length of the nanowires is around 30 μm. The nanowires were separated from the substrate and broken into small fragments to form PSiNPs via sonication (). PSiNPs with different sizes were then separated by using filtration membranes. The size chosen for this study was between 200-400 nm, which is suitable for conducting
in vitro studies. shows the TEM image of PSiNPs after sonication, from which their average length is estimated to be about 300 nm, in agreement with the result obtained from dynamic light scattering measurements (
Supporting Information Page S3). The pore structure can be clearly observed via HR-TEM ( inset). N
2 adsorbtion-desorption analysis gives a BET surface area of 293 m
2/g and a pore volume of 0.98 cc/g, consistent with a previous report.
8c These PSiNPs exhibit a relatively wide pore size distribution (
Supporting Information Page S3) due to the variable sizes of the nucleated Ag nanoparticles on the sidewall of the silicon nanowires.
In this study, a well-established pH-responsive nanovalve-system consisting of an aromatic amino group and a cyclodextrin cap
9d,9f was chosen to be adapted to the PSiNPs. This nanovalve was shown to be tightly closed under physiological pH (pH 7.4) and to open autonomously under acidic conditions (pH<6) present in endosomal/lysomal vesicles. In order to attach the nanovalves, The PSiNPs were first derivatized with 3-iodopropyltrimethoxysilane and then coupled with a benzimidazole molecule under base catalysis (). Solid state NMR spectrum proves that the modification was successful (
Supporting Information Page S4). The modified PSiNPs exhibit a BET surface area of 282 m
2/g and a pore volume of 0.95 cc/g, which is similar to those before modification.
In order to demonstrate the operation of the nanovalves, the fluorescent biological staining dye Hoechst 33342 was chosen as a model cargo. The PSiNPs were loaded with the dye by soaking them in a concentrated Hoechst 33342 solution. β-cyclodextrin was then added into the solution to finish the full assembly of the nanovalves, followed by washing with water to remove dye molecules absorbed on the nanoparticles’ exteriors. Under neutral pH conditions, the benzimidazole stalk remains hydrophobic and therefore can bind to the cyclodextrin molecule via supramolecular interactions. By doing this, the bulky cyclic cyclodextrin molecules block the pore openings and function as gate keepers to prevent the cargo in the pore from leaking out. When the pH is lowered, the benzimidazole is protonated, and the binding constant between the stalk and the cyclodextrin drops dramatically, causing the cyclodextrin to dissociate. After the pores are unblocked, the cargo can diffuse out ().
In order to verify the functional operation of the nanovalves, the cargo-loaded PSiNPs were placed in water and the pH was lowered to stimulate the opening of the nanovalves. The increased concentration of cargo dye released into the aqueous solution was monitored as a function of time by fluorescence spectroscopy to generate a release profile (). Similar to the behavior in the case of silica nanoparticles,
9f these nanovalves on silicon nanoparticles remain tightly closed at pH 7.0, giving a flat baseline as illustrated in . Upon lowering the pH, the nanovalves opened and the cargo was released. Cargo release was completed in about 3 hr, which is much faster than that in the case of MCM-41. As a control experiment, PSiNPs with stalks but without capping components were used. In this case, all of the cargo should be removed from PSiNPs during washing. The flat profile for these PSiNPs observed upon acidification shows that no cargo was released as expected ().
The loading capacity of these PSiNPs is dependent on the size of the cargo. In the case of Hoechst, a loading capacity of 1% w/w was determined using UV-vis absorbtion spectroscopy. This relatively low value is due to the small size of the Hoechst molecules. The nanovalve on the PSiNPs has a size of about 1.5 nm, thus is only capable of controlling the release of Hoechst from < 5.5 nm sized pores.
13Before conducting in vitro studies, it is important to verify that the nanovalve-modified PSiNPs remain functional in biological conditions where the large amount of buffering salt and proteins could potentially change the behavior of the nanovalves. In order to address this point, release profiles were generated in a DMEM cell culture medium with 10% FBS, using Hoechst-loaded PSiNPs (). The PSiNPs were stable in the cell culture medium for at least 5 hr, as no cargo leakage was observed. When the pH was lowered, the fluorescence intensity increased over time, indicating that the valves opened and released cargo. This result demonstrates that the nanovalve-modified PSiNPs are stable, functional and suitable for utilization as a drug delivery system.
Human pancreatic carcinoma PANC-1 cells were studied in order to prove that the nanovalve-modified PSiNPs can be taken up by cells and deliver their cargo inside them. The cells were incubated at 37 °C with the fluorescein-labeled PSiNPs that were loaded with Hoechst 33342. shows that after incubation for three hours, the Hoechst dye was released and stained the cell nucleus. This process is relatively fast and is consistent with the abiotic release profile. In order to further prove that it is the endocytosed PSiNPs that opened and released the dye, several control experiments were conducted. First, the cells were incubated at 4 °C, where the energy-dependant endocytosis pathway is inactive, with the same amount of PSiNPs. In principle, if it is the nanovalves that control the release of the dye, then non-endocytosed PSiNPs should not stain the cells because they do not experience a pH change. As shown in , no staining was observed after 3 hrs’ incubation at low temperature, proving that the dye is not released. Furthermore, contact between PSiNPs and the cell membrane does not cause the nanovalves to open. This result also suggests that the endocytosis process is necessary for opening the nanovalves. Secondly, in order to further investigate the functioning of the mechanized PSiNPs, a competition experiment was conducted. The cells were treated with the same amount of Hoechst-loaded FITC-labeled PSiNPs and increasing amounts of plain PSiNPs with no payload or FITC-labeling. If the particles are indeed taken up primarily via a specific energy dependant uptake process, the amount of FITC-labeled particle uptake (and nuclear staining) should decrease as the concentration of unlabelled particles increases. prove this assumption by showing much less FITC signal along with less nuclear staining. This result demonstrates that the nanovalves on the PSiNPs do not open in cell culture medium at 37 °C, and also proves that the endocytosis process is necessary to enable the particles to reach lysosomes and trigger the release of the cargo.
In summary, we have demonstrated that pH-sensitive nanovalves can be successfully grafted onto the surface of PSiNPs and function as valves to control the pore openings. These mechanized PSiNPs are endocytosed and release their cargo molecules inside the cells. Further studies regarding controlling the larger sized pores, optimizing the system, and understanding the biological process are in progress.